Drug Research
Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, NY
Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Syracuse, NY to Lotte Biologics.
The divestiture is part of Bristol...
Drug Research
Hong Kong University Develops Bone Anabolic Therapy Aptamer
The molecular target for bone anabolic therapy has been discovered by a research team headed by Hong Kong Baptist University (HKBU), utilising a particular...
Drug Research
Nykode Therapeutics and Richter-Helm BioLogics Enter Manufacturing Partnership
Nykode Therapeutics, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, has entered into a manufacturing partnership with Richter-Helm BioLogics...
News
NHS Cancer Treatment Rates Highest Ever Recorded In 2022
The NHS has released encouraging statistics regarding cancer rates in the UK to kick off the new year. Over the past year, more patients...
Drug Research
Antibiotic Resistance Being Weakened By Persistent Bacteria
Researchers from Uppsala University in Sweden have released a study on how various antibiotic treatments affect different types of bacteria and how they respond...
Clinical Trials
CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology
CardieX Limited, a global health technology company focused on patient-centric healthcare research and improving clinical trial patient outcomes announced a partnership between its ATCOR...
Press Releases
Hetero’s ‘NIRMACOM’ is world’s first generic version of COVID-19 oral drug PAXLOVID to receive WHO Prequalification
Hetero, India’s leading pharmaceutical company with the widest global reach, announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read